News | October 09, 2013

Elekta Announces Latest Leksell GammaPlan Connectivity With MOSAIQ Oncology Information System

Kettering Medical Center creates Mosaiq electronic medical records of patients receiving Gamma Knife radiosurgery

radiation therapy oncology information management systems oims elekta

October 9, 2013 — Since December 2012, clinicians at Kettering Medical Center have been able to access — on Elekta’s Mosaiq Oncology Information Management System — the electronic medical records of patients who undergo treatment on the facility’s Leksell Gamma Knife Perfexion system. Leksell GammaPlan Connectivity provides integration with Mosaiq for complete patient charting and a streamlined clinical workflow.

“The complete picture of any Gamma Knife patient’s case is accessible from any Mosaiq workstation in the hospital – just like any patient receiving linac-based radiotherapy,” said Christopher Wennerstrom, M.S., diplomat, American Board of Radiology (ABR) and physicist, Kettering Medical Center. “We can bring up the treatment plan from Leksell GammaPlan with details including the total dose to the lesion, each beam’s coordinates, all the gamma angles and the images of the relevant radiosurgery shots. It’s invaluable. You can recreate what happened to the patient from the Mosaiq record.”

In addition to importing all historical, current and future Gamma Knife plans into Mosaiq, clinical users can also interface with billing systems, import appointment scheduling and lab results, and export lab orders. In addition, eScribe in Mosaiq enables clinical merge fields to be automated into documents, reducing administration time and freeing up clinical resources. Mosaiq also features Quality Assurance tools to support patient safety. Mosaiq Evaluate provides the clinical staff with side-by-side comparison of plans from any oncology treatment planning system allowing plan review and approval in a distributed manner.  Workflow automation can be customized to meet the unique needs of the center using Mosaiq IQ Scripts.

“Our Gamma Knife program used to be an island with its own method of maintaining electronic medical records, but now that it is united in Mosaiq with the radiation therapy department, it has become a very efficient way to track the treatment history of all patients receiving some form of radiation therapy,” said Wennerstrom. “Having all your patient records available for your clinicians when they have to make their decisions is a huge patient benefit. Equally important, since all the Gamma Knife isocenters and prescriptions go into Mosaiq, patient safety is enhanced.”

Kettering Medical Center has been operating Gamma Knife technology since 1999, and acquired the latest generation system, Leksell Gamma Knife Perfexion, in 2009. Presently, Kettering treats about 150 patients per year with this system.

For more information: www.elekta.com

Related Content

Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...